Sc China Holding LTD Roivant Sciences Ltd. Transaction History

Sc China Holding LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$8.38 - $11.58 $10.5 Million - $14.5 Million	-1,249,999 Reduced 48.15%	1,345,839 $15.1 Million
Q2 2023 Aug 14, 2023	SELL	$7.09 - $10.08 $9.23 Million - $13.1 Million	-1,301,355 Reduced 33.39%	2,595,838 $26.2 Million
Q1 2023 May 15, 2023	SELL	$6.92 - $9.98 $9.05 Million - $13.1 Million	-1,308,225 Reduced 25.13%	3,897,193 $28.8 Million
Q2 2022 Aug 15, 2022	BUY	$2.81 - $4.84 $706,529 - $1.22 Million	251,434 Added 5.08%	5,205,418 $21.2 Million
Q4 2021 Feb 14, 2022	BUY	$5.86 - $13.52 $29 Million - $67 Million	4,953,984 New	4,953,984 $49.9 Million

310

507M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.51B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Sc China Holding LTD, based on Form 13F filings with the SEC.

Stay updated on Sc China Holding LTD with notifications on news.